Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Seripa

Showing results (161-170 of 225) with videos related to

Pageof 23
Sort By:
Expert Opinion on Pharmacotherapy|May 5, 2018
Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorderMadia Lozupone, Maddalena La Montagna, Francesca D'Urso, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 28, 2022
Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?Madia Lozupone, Bruno Pietro Imbimbo, Claudia Balducci, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 19, 2012
Frailty syndrome and the risk of vascular dementia: the Italian Longitudinal Study on AgingVincenzo Solfrizzi, Emanuele Scafato, Vincenza Frisardi, et al.
Expert Opinion on Emerging Drugs|September 29, 2016
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patientsFrancesco Panza, Davide Seripa, Vincenzo Solfrizzi, et al.
International Journal of Molecular Epidemiology and Genetics|April 12, 2012
Genetic variation in MME in relation to neprilysin protein and enzyme activity, Aβ levels, and Alzheimer's disease riskScott Miners, Zoë van Helmond, Rachel Barker, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 10, 2009
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's diseaseCristiano Capurso, Vincenzo Solfrizzi, Anna Maria Colacicco, et al.
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to PreventionFrancesco Panza, Madia Lozupone, Vincenzo Solfrizzi, et al.
Journal of Alzheimer'S Disease : JAD|June 7, 2017
Midlife Metabolic Profile and the Risk of Late-Life Cognitive DeclineRosanna Tortelli, Madia Lozupone, Vito Guerra, et al.
Translational Neurodegeneration|February 9, 2019
Hydroxytryptamine transporter gene-linked polymorphic region (5HTTLPR) is associated with delusions in Alzheimer's diseaseGrazia D'Onofrio, Francesco Panza, Daniele Sancarlo, et al.
Pain Medicine (Malden, Mass.)|May 20, 2015
Role of CYP2D6 Polymorphisms in the Outcome of Postoperative Pain TreatmentDavide Seripa, Paola Latina, Andrea Fontana, et al.
Pageof 23

Showing results (161-170 of 225) with videos related to

Sort By:
Pageof 23
Expert Opinion on Pharmacotherapy|May 5, 2018
Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorderMadia Lozupone, Maddalena La Montagna, Francesca D'Urso, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 28, 2022
Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?Madia Lozupone, Bruno Pietro Imbimbo, Claudia Balducci, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 19, 2012
Frailty syndrome and the risk of vascular dementia: the Italian Longitudinal Study on AgingVincenzo Solfrizzi, Emanuele Scafato, Vincenza Frisardi, et al.
Expert Opinion on Emerging Drugs|September 29, 2016
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patientsFrancesco Panza, Davide Seripa, Vincenzo Solfrizzi, et al.
International Journal of Molecular Epidemiology and Genetics|April 12, 2012
Genetic variation in MME in relation to neprilysin protein and enzyme activity, Aβ levels, and Alzheimer's disease riskScott Miners, Zoë van Helmond, Rachel Barker, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 10, 2009
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's diseaseCristiano Capurso, Vincenzo Solfrizzi, Anna Maria Colacicco, et al.
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to PreventionFrancesco Panza, Madia Lozupone, Vincenzo Solfrizzi, et al.
Journal of Alzheimer'S Disease : JAD|June 7, 2017
Midlife Metabolic Profile and the Risk of Late-Life Cognitive DeclineRosanna Tortelli, Madia Lozupone, Vito Guerra, et al.
Translational Neurodegeneration|February 9, 2019
Hydroxytryptamine transporter gene-linked polymorphic region (5HTTLPR) is associated with delusions in Alzheimer's diseaseGrazia D'Onofrio, Francesco Panza, Daniele Sancarlo, et al.
Pain Medicine (Malden, Mass.)|May 20, 2015
Role of CYP2D6 Polymorphisms in the Outcome of Postoperative Pain TreatmentDavide Seripa, Paola Latina, Andrea Fontana, et al.
Pageof 23